Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Download Supplementary Information
Document related concepts
no text concepts found
Transcript
Christopher R. Kinsinger,* Office of Cancer Clinical Proteomics Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States James Apffel, Agilent Research Laboratories, Santa Clara, California 95051, United States Mark Baker, Department of Chemistry & Biomolecular Sciences, Macquarie University, Sydney, Australia New South Wales 2109 Xiaopeng Bian, Center for Bioinformatics and Information Technology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States Christoph H. Borchers, Genome BC Proteomics Centre, University of Victoria, Victoria, British Columbia, Canada V8Z 7X8 Ralph Bradshaw, Mass Spectrometry Facility, University of California, San Francisco, California 94143, United States Mi-Youn Brusniak, Institute of Systems Biology, Seattle, Washington 98103, United States Daniel W. Chan, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, United States Eric W. Deutsch, Institute for Systems Biology, Seattle, Washington 98109, United States Bruno Domon, Luxembourg Clinical Proteomics Center, CRP-Sante, Strassen, Luxembourg, L-1445 Jeff Gorman, Protein Discovery Centre, Queensland Institute of Medical Research, Herston, Queensland, Australia 4029 Rudolf Grimm, Agilent Technologies, Santa Clara, California 95051, United States William Hancock, Department of Chemistry & Chemical Biology, Northeastern University, Boston, Massachusetts 02115, United States Henning Hermjakob, Proteomics Services, European Bioinformatics Institute, Cambridge, United Kingdom CB10 1SD David Horn, Proteomics Software Strategic Marketing, Thermo Fisher Scientific, San Jose, California 95134, United States Christie Hunter, AB SCIEX, Foster City, California 94404, United States Patrik Kolar, Directorate-General for Research, European Commission, Brussels, Belgium, B-1049 Hans-Joachim Kraus, Wiley-VCH, Weinheim, Germany, D-69469 Hanno Langen, Exploratory Biomarkers, Hoffmann-La Roche, Basel, Switzerland, 4070 Rune Linding, The Technical University of Denmark (DTU), Cellular Signal Integration Group (C-SIG), Center for Biological Sequence Analysis (CBS), Department of Systems Biology DK-2800 Lyngby, Denmark Robert L. Moritz, Cellular & Molecular Logic Unit, Institute of Systems Biology, Seattle, Washington 98103, United States Gilbert S. Omenn, Center for Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan 48109, United States Ron Orlando, Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia 30602, United States Akhilesh Pandey, McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University, Baltimore, Maryland 21231, United States Peipei Ping, David Geffen School of Medicine, University of California, Los Angeles, California 90095, United States Amir Rahbar, Small Business Development Center, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States Robert Rivers, Office of Cancer Clinical Proteomics Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States Sean L. Seymour, AB Sciex, Foster City, California 94404, United States Richard J. Simpson, La Trobe Institute for Molecular Science, L Trobe University, Bundoora, Victoria 3086, Australia Douglas Slotta, National Center for Biotechnology Information, National Institutes of Health, Bethesda, Maryland 20892, United States Richard D. Smith, Pacific Northwest National Laboratory, Richland, Washington 99352, United States Stephen E. Stein, Chemical Reference Data Group, National Institute of Standards and Technology, Gaithersburg, Maryland 20899, United States David L. Tabb, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee 37232, United States Danilo Tagle, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, United States John R. Yates, III, The Scripps Research Institute, The Scripps Research Institute, La Jolla, California 92037, United States Henry Rodriguez Office of Cancer Clinical Proteomics Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States
Related documents